Other languages BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
38.92 ^CNY	-0.38%		+1.22%	-18.92%

Apr. 15	BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	CI
Mar. 01	BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2023	Apr. 15
BGI Genomics' 2023 Profit Falls 89% as Revenue Plunges 38%	Feb. 29
BGI Genomics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29
China stocks rise further on market rescue hopes; HK flat	Feb. 06
Wuxi AppTec Denies Ties to Military in Wake of US Draft Bill Targeting Chinese Biotech Firms	Feb. 05
US bill targeting Chinese biotech firms WuXi AppTec, BGI hits delay	Feb. 02
EEUU denuncia a las empresas chinas que ayudan al ejército de Pekín	Feb. 01
Correction: Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	Jan. 29
Chinese Shares End Lower on US Draft Bill Targeting Chinese Biotech Firms; MGI Slumps 12%, Wuxi AppTec Falls 9%	Jan. 29
US House bill would curb genetic info sharing with China's Wuxi Apptec, BGI	Jan. 26
BGI Genomics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27
Chinese Shares Extend Losses as Bank Borrowing Plunges to 14-Year Low; BGI Falls 6% After M&A Announcement	23-08-14
BGI Genomics to Acquire Health Management Firm; Shares Slump 6%	23-08-14
BGI Genomics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-11
BGI Genomics Appoints COO	23-06-30
Bgi Genomics Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 7 June 2023	23-05-31
Bgi Genomics Co., Ltd. Approves Cash Dividend for 2022	23-05-10
BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25
BGI Genomics Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-31
BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia	23-03-29

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages BGI Genomics Co., Ltd.

Equities

300676

CNE100003449

Other languages

Filters